Monoclonal Antibody Generation Using Single B Cell Screening for Treating Infectious Diseases
Open Access
- 2 July 2024
- journal article
- research article
- Published by Springer Nature in BioDrugs
- Vol. 38 (4) , 477-486
Abstract
The screening of antigen-specific B cells has been pivotal for biotherapeutic development for over four decades. Conventional antibody discovery strategies, including hybridoma technology and single B cell screening, remain widely used based on their simplicity, accessibility, and proven track record. Technological advances and the urgent demand for infectious disease applications have shifted paradigms in single B cell screening, resulting in increased throughput and decreased time and labor, ultimately enabling the rapid identification of monoclonal antibodies with desired biological and biophysical properties. Herein, we provide an overview of conventional and emergent single B cell screening approaches and highlight their potential strengths and weaknesses. We also detail the impact of innovative technologies—including miniaturization, microfluidics, multiplexing, and deep sequencing—on the recent identification of broadly neutralizing antibodies for infectious disease applications. Overall, the coronavirus disease 2019 (COVID-19) pandemic has reinvigorated efforts to improve the efficiency of monoclonal antibody discovery, resulting in the broad application of innovative antibody discovery methodologies for treating a myriad of infectious diseases and pathological conditions.Keywords
Funding Information
- National Institute of General Medical Sciences (R35GM136300)
- National Institute on Aging (R01AG080016)
- National Institute of Neurological Disorders and Stroke (R21NS132018)
- Division of Microbiology and Infectious Diseases (R21AI171844)
This publication has 53 references indexed in Scilit:
- Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donorCell Reports, 2023
- LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variantsCell Reports, 2022
- Antibody stability: A key to performance - Analysis, influences and improvementBiochimie, 2020
- High-Throughput Mapping of B Cell Receptor Sequences to Antigen SpecificityCell, 2019
- Assuring Clonality on the Beacon Digital Cell Line Development PlatformBiotechnology Journal, 2019
- Engineering therapeutic antibodies to combat infectious diseasesCurrent Opinion in Chemical Engineering, 2018
- Molecular and functional analysis of monoclonal antibodies in support of biologics developmentProtein & Cell, 2017
- Strategies to guide the antibody affinity maturation processCurrent Opinion in Virology, 2015
- Production of Human or Humanized Antibodies in Mice2012
- Hybridoma Technology for the Generation of Monoclonal Antibodies2012